| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 3.4e-05 | 1 |